The primary goal of this study was to determine the impact of global HIF2α inhibition in preventing and reverting pulmonary hypertension and to investigate the pathological influence of this transcription factor in regulating the expression of potential PH associated target genes that systematically influence vascular homeostasis. This evidence concerns the gene EPAS1 and pulmonary arterial hypertension.